Hyltoft Petersen P - Search Results

1

Progression criteria for cancer antigen 15.3 and carcinoembryonic antigen in metastatic breast cancer compared by computer simulation of marker data.

Sölétormos G, Hyltoft Petersen P, Dombernowsky P. Sölétormos G, et al. Among authors: hyltoft petersen p. Clin Chem. 2000 Jul;46(7):939-49. Clin Chem. 2000. PMID: 10894837

2

Design of tumor biomarker-monitoring trials: a proposal by the European Group on Tumor Markers.

Sölétormos G, Duffy MJ, Hayes DF, Sturgeon CM, Barak V, Bossuyt PM, Diamandis EP, Gion M, Hyltoft-Petersen P, Lamerz RM, Nielsen DL, Sibley P, Tholander B, Tuxen MK, Bonfrer JM. Sölétormos G, et al. Among authors: hyltoft petersen p. Clin Chem. 2013 Jan;59(1):52-9. doi: 10.1373/clinchem.2011.180778. Epub 2012 Oct 3. Clin Chem. 2013. PMID: 23034139

3

Valid analytical performance specifications for combined analytical bias and imprecision for the use of common reference intervals.

Hyltoft Petersen P, Lund F, Fraser CG, Sandberg S, Sölétormos G. Hyltoft Petersen P, et al. Ann Clin Biochem. 2018 Sep;55(5):612-615. doi: 10.1177/0004563217752963. Epub 2018 Jan 30. Ann Clin Biochem. 2018. PMID: 29310466

4

Creation of a low-risk reference group and reference interval of fasting venous plasma glucose.

Jørgensen LG, Brandslund I, Hyltoft Petersen P, Stahl M, de Fine Olivarius N. Jørgensen LG, et al. Among authors: hyltoft petersen p. Clin Chem Lab Med. 2004;42(7):817-23. doi: 10.1515/CCLM.2004.135. Clin Chem Lab Med. 2004. PMID: 15327018

5

Graphical interpretation of confidence curves in rankit plots.

Hyltoft Petersen P, Blaabjerg O, Andersen M, Jørgensen LG, Schousboe K, Jensen E. Hyltoft Petersen P, et al. Clin Chem Lab Med. 2004;42(7):715-24. doi: 10.1515/CCLM.2004.122. Clin Chem Lab Med. 2004. PMID: 15327005 Review.

6

Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.

von Eyben FE, Blaabjerg O, Hyltoft-Petersen P, Madsen EL, Amato R, Liu F, Fritsche H. von Eyben FE, et al. Among authors: hyltoft petersen p. Clin Chem Lab Med. 2001 Jan;39(1):38-44. doi: 10.1515/CCLM.2001.010. Clin Chem Lab Med. 2001. PMID: 11256799

7

Improved RNase protection assay for quantifying LDL-receptor mRNA; estimation of analytical imprecision and biological variance in peripheral blood mononuclear cells.

Petersen NE, Larsen LK, Nissen H, Jensen LG, Jensen A, Hyltoft Petersen P, Hørder, Gregersen N, Kristiansen K. Petersen NE, et al. Among authors: hyltoft petersen p. Clin Chem. 1995 Nov;41(11):1605-13. Clin Chem. 1995. PMID: 7586550

8

Should we maintain the 95 percent reference intervals in the era of wellness testing? A concept paper.

Jørgensen LG, Brandslund I, Hyltoft Petersen P. Jørgensen LG, et al. Among authors: hyltoft petersen p. Clin Chem Lab Med. 2004;42(7):747-51. doi: 10.1515/CCLM.2004.126. Clin Chem Lab Med. 2004. PMID: 15327009

9

How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?

Jørgensen LG, Fredholm L, Hyltoft Petersen P, Hey H, Munkholm P, Brandslund I. Jørgensen LG, et al. Among authors: hyltoft petersen p. Clin Chem Lab Med. 2005;43(4):403-11. doi: 10.1515/CCLM.2005.073. Clin Chem Lab Med. 2005. PMID: 15899657

10

Robust nonradioactive oligonucleotide ligation assay to detect a common point mutation in the CYP2D6 gene causing abnormal drug metabolism.

Hansen TS, Petersen NE, Iitiä A, Blaabjerg O, Hyltoft-Petersen P, Hørder M. Hansen TS, et al. Among authors: petersen ne, hyltoft petersen p. Clin Chem. 1995 Mar;41(3):413-8. Clin Chem. 1995. PMID: 7882517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters